Assignee profile:

Altor Bioscience, LLC

City:

Culver City, California

Country:

United States

Published Applications:

33

Last publication date:

2025-01-16

Patent Grants:

33

Last grant date:

2025-02-25

Top Inventors for applications by Altor Bioscience, LLC

These are the the leading inventors for applications assigned to Altor Bioscience, LLC:

Recent patent applications by Altor Bioscience, LLC

Altor Bioscience, LLC based in Culver City, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-01-16 ✅ Patent 12,233,116 granted on 2025-02-25
US20250018020A1
Human necessities

IL-15-based fusions to IL-12 and IL-18

#2 | 2024-09-19 ✅ Patent 12,318,432 granted on 2025-06-03
US20240307495A1
Human necessities

BCG and IL-15 based molecules

#3 | 2024-09-19 ✅ Patent 12,268,732 granted on 2025-04-08
US20240307494A1
Human necessities

IL-15-based molecules with anti-CD20 antibody and methods of use

#4 | 2024-08-01 ✅ Patent 12,268,731 granted on 2025-04-08
US20240252591A1
Human necessities

Compositions comprising IL-15N72D-based molecules and bacillus calmette-guerin (BCG)

#5 | 2024-04-25 ✅ Patent 12,097,244 granted on 2024-09-24
US20240131115A1
Human necessities

Methods of treating a neoplasia with IL-15-based molecules and CTLA-4 antibody

#6 | 2024-03-28 ✅ Patent 11,975,059 granted on 2024-05-07
US20240100138A1
Human necessities

IL-15-based fusions to IL-12 and IL-18

#7 | 2024-03-07 ✅ Patent 12,371,472 granted on 2025-07-29
US20240076354A1
Chemistry; metallurgy

MULTIMERIC IL-15 SOLUBLE FUSION MOLECULES AND METHODS OF MAKING AND USING SAME

#8 | 2024-03-07 ✅ Patent 12,410,224 granted on 2025-09-09
US20240076340A1
Chemistry; metallurgy

IL-15-BASED FUSIONS TO IL-7 AND IL-21

#9 | 2023-08-17 ✅ Patent 12,168,680 granted on 2024-12-17
US20230257437A1
Chemistry; metallurgy

Fusion molecules and IL-15 variants

#10 | 2023-08-10 ✅ Patent 11,872,272 granted on 2024-01-16
US20230248813A1
Human necessities

IL-15-based fusions to IL-12 and IL-18

#11 | 2023-08-03 ✅ Patent 12,186,372 granted on 2025-01-07
US20230241175A1
Human necessities

IL-15-based molecules and methods of treating a neoplasia

#12 | 2023-08-03 ✅ Patent 11,890,323 granted on 2024-02-06
US20230241174A1
Human necessities

Method of treating cancer with composition comprising IL-15-based molecules and BCG

#13 | 2023-07-27 ✅ Patent 11,925,676 granted on 2024-03-12
US20230233649A1
Human necessities

Method for treating neoplasia with an anti-CD38 antibody and an IL-15:IL-15R complex

#14 | 2023-06-22 ✅ Patent 11,992,516 granted on 2024-05-28
US20230190877A1
Human necessities

Compositions comprising IL-15-based molecules and immune checkpoint inhibitor antibodies

#15 | 2022-12-08 ✅ Patent 11,612,645 granted on 2023-03-28
US20220387570A1
Human necessities

IL-15-based fusions to IL-12 and IL-18

#16 | 2022-11-15 ✅ Patent 11,498,950 granted on 2022-11-15
US16659311
Chemistry; metallurgy

Fusion molecules and IL-15 variants

#17 | 2022-09-29 ✅ Patent 11,679,144 granted on 2023-06-20
US20220305087A1
Human necessities

IL-15-based molecules and methods of use thereof

#18 | 2022-09-08 ✅ Patent 11,673,932 granted on 2023-06-13
US20220281937A1
Chemistry; metallurgy

Fusion molecules and IL-15 variants

#19 | 2022-03-31 ✅ Patent 12,325,734 granted on 2025-06-10
US20220098268A1
Chemistry; metallurgy

HUMAN IMMUNODEFICIENCY VIRUS-SPECIFIC T CELL RECEPTORS

#20 | 2022-03-03 ✅ Patent 11,571,470 granted on 2023-02-07
US20220062399A1
Human necessities

IL-15-based fusions to IL-12 and IL-18

#21 | 2022-02-03 ✅ Patent 11,965,007 granted on 2024-04-23
US20220033455A1
Chemistry; metallurgy

IL-15-based fusions to IL-7 and IL-21

#22 | 2022-01-06 ✅ Patent 11,845,783 granted on 2023-12-19
US20220002383A1
Chemistry; metallurgy

Multimeric IL-15 soluble fusion molecules and methods of making and using same

#23 | 2021-07-01 ✅ Patent 11,197,929 granted on 2021-12-14
US20210196821A1
Human necessities

Multimeric IL-15-based molecules

#24 | 2021-02-04 ✅ Patent 11,471,511 granted on 2022-10-18
US20210030844A1
Human necessities

IL-15-based molecules and methods of use thereof

#25 | 2020-08-20 ✅ Patent 11,369,679 granted on 2022-06-28
US20200261575A1
Human necessities

Multimeric IL-15-based molecules

#26 | 2020-06-11 ✅ Patent 11,104,716 granted on 2021-08-31
US20200181237A1
Chemistry; metallurgy

Multimeric IL-15 soluble fusion molecules and methods of making and using same

#27 | 2020-05-07 ✅ Patent 11,365,231 granted on 2022-06-21
US20200140513A1
Chemistry; metallurgy

Interleukin 15 (IL-15) variants

#28 | 2020-01-16 ✅ Patent 11,173,191 granted on 2021-11-16
US20200016239A1
Human necessities

IL-15-based molecules and methods of use thereof

#29 | 2020-01-02 ✅ Patent 11,168,138 granted on 2021-11-09
US20200002425A1
Chemistry; metallurgy

Anti-PDL1, IL-15 and TGF-beta receptor combination molecules

#30 | 2019-10-03 ✅ Patent 11,161,890 granted on 2021-11-02
US20190300591A1
Chemistry; metallurgy

IL-15-based fusions to IL-7 and IL-21

#31 | 2019-02-14 ✅ Patent 11,129,883 granted on 2021-09-28
US20190046623A1
Human necessities

IL-15-based fusions to IL-12 and IL-18

#32 | 2017-11-30 ✅ Patent 10,865,230 granted on 2020-12-15
US20170342119A1
Chemistry; metallurgy

Construction and characterization of multimeric IL-15-based molecules with CD3 binding domains

#33 | 2016-10-27 ✅ Patent 11,261,231 granted on 2022-03-01
US20160311890A1
Chemistry; metallurgy

Methods for inhibiting HIV or HCV infection by administering TIM-3 binding inhibitors

Also check out Altor Bioscience, LLC.'s (Culver City, United States) applicant profile with 30 patent applications submitted.

AssigneeID:

350573 ⎘